Progress in Neuro-Psychopharmacology and Biological Psychiatry

Editorial Board
pp. CO2-CO2(1)

Apoptosis and human neurodegenerative diseases
pp. 197-198(2)
Authors: Berry M.D.; Boulton A.A.

Apoptotic signaling cascades
pp. 199-214(16)
Authors: Ashe P.C.; Berry M.D.

Natural cellular inhibitors of caspases
pp. 215-229(15)
Author: LeBlanc A.C.

A simple, informative, and quantitative flow cytometric method for assessing apoptosis in cultured cells
pp. 231-243(13)
Authors: Warrington R.C.; Norum J.N.; Hilchey J.L.; Watt C.; Fang W.D.

Apoptosis and Parkinson's disease
pp. 245-250(6)
Authors: Lev N.; Melamed E.; Offen D.

Apoptotic promoters and inhibitors in Alzheimer's disease: Who wins out?
pp. 251-254(4)
Authors: Raina A.K.; Hochman A.; Ickes H.; Zhu X.; Ogawa O.; Cash A.D.; Shimohama S.; Perry G.; Smith M.A.

Apoptosis in Huntington's disease
pp. 255-265(11)
Authors: Hickey M.A.; Chesselet M.-F.

Apoptosis and brain ischaemia
pp. 267-282(16)
Author: Love S.

A new view of diabetic retinopathy: a neurodegenerative disease of the eye
pp. 283-290(8)
Author: Barber A.J.

Proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase: a possible site of action of antiapoptotic drugs
pp. 291-301(11)
Authors: Ishitani R.; Tajima H.; Takata H.; Tsuchiya K.; Kuwae T.; Yamada M.; Takahashi H.; Tatton N.A.; Katsube N.

Prospects for antiapoptotic drug therapy of neurodegenerative diseases
pp. 303-321(19)
Author: Waldmeier P.C.

In vivo monitoring of apoptosis
pp. 323-331(9)
Author: Brauer M.